Genmab — Februar 2021
-
Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation https://onlinelibrary.wiley.com/doi/abs/10.1111/trf.16281?af=R
-
Imponerende 105.000 aktier omsat i dag.... har der været handelsstop?
-
God morgen.
-
Asien: Fremgang overalt - Hongkong undtagethttps://www.proinvestor.com/investornyt/671711/asien-fremgang-overalt-hongkong-undtaget
-
Onsdagens aviser med Coloplast, Novozymes og Bavarian https://www.proinvestor.com/investornyt/671710/onsdagens-aviser-med-coloplast-novozymes-og-bavarian
-
Amgen's BCMA Bispecific: AMG 701 Enrollment in the Phase 1 study has been paused while we discuss protocol modifications to optimize safety monitoring and mitigation with the FDA. Currently enrolled patients who are demonstrating benefit may continue to receive investigational product and the Company expects to resume patient enrollment in H1 2021. (Teclistamab rival)
-
"Uptake of KYPROLIS in combination with DARZALEX
(daratumumab) plus dexamethasone (DKd) in the U.S. has been encouraging as reflected in new patient share, and we expect this momentum to continue into 2021 with additional global regulatory approvals of the DKd combination." -
"Der er så stille nu"...måske stilhed før storm:-)
-
ADS US under 40
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind